<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="56903">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01760733</url>
  </required_header>
  <id_info>
    <org_study_id>STHF 81.25</org_study_id>
    <nct_id>NCT01760733</nct_id>
  </id_info>
  <brief_title>Health Related Quality of Life in ESRD Patients Older Than 65 Years</brief_title>
  <acronym>QUESTION65</acronym>
  <official_title>Health Related Quality of Life in ESRD Patients Older Than 65 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sykehuset Telemark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sykehuset Telemark</source>
  <oversight_info>
    <authority>Norway: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Kidney transplantation has been shown to provide improved survival even in patients older
      than 70 years of age. The purpose of the study is to determine whether kidney
      transplantation provides any improvement of health related quality of life (HRQOL) in
      patients over the age of 65 years. HRQOL wil be monitored using the Kidney Disease and
      Quality of Life (KDQOL-SF)form. Patients will be recruited at the time of acceptance to the
      Norwegian transplant wait list and followed every 6 months until 1 year after
      transplantation. Thereafter a new form will be completed after 3 years and 5 years.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Health related quality of life</measure>
    <time_frame>Change in HRQOL from  baseline to 12 months after kidney transplantation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Longitudinally monitoring of HRQOL from listing for transplantation and up to 5 years post transplantation</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Quality of Life</condition>
  <condition>End Stage Renal Disease</condition>
  <condition>End Stage Renal Failure on Dialysis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients older than 65 years listed for kidney transplantation on the Norwegian transplant
        wait list
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  End stage renal disease listed for transplantation

          -  Age &gt; 65 years

        Exclusion Criteria:

          -  Not able to fulfill the HRQOL form
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristian Heldal, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sykehuset Telemark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kjersti Lønning, MSm</last_name>
    <phone>+4723073647</phone>
    <email>klonning@ous-hf.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>Oslo University Hospital, Rikshospitalet, Section of Nephrology</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kjersti Lønning, MSm</last_name>
      <phone>+4723073647</phone>
      <email>klonnin@ous-hf.no</email>
    </contact>
    <contact_backup>
      <last_name>Karsten Midtvedt, MD, PhD</last_name>
      <phone>+4723071894</phone>
      <email>kmidtved@ous-hf.no</email>
    </contact_backup>
    <investigator>
      <last_name>Karsten Midtvedt, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 2, 2013</lastchanged_date>
  <firstreceived_date>December 17, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sykehuset Telemark</investigator_affiliation>
    <investigator_full_name>Kristian Heldal</investigator_full_name>
    <investigator_title>Senior Physician, PhD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
